Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-23T09:09:00.686Z Has data issue: false hasContentIssue false
  • English
  • Français

Modafinil monotherapy in depression

Published online by Cambridge University Press:  16 April 2020

Kenneth R. Kaufman ,
Matthew A. Menza  and
Adriana Fitzsimmons
Kenneth R. Kaufman*
Affiliation:
Department of Psychiatry, UMDNJ-Robert Wood Johnson Medical School, 125 Paterson Street, Suite, #2200, NJ 08901, USA Department of Neurology, UMDNJ-Robert Wood Johnson Medical School, 125 Paterson Street, Suite #2200, NJ 08901, USA
Matthew A. Menza
Affiliation:
Department of Psychiatry, UMDNJ-Robert Wood Johnson Medical School, 125 Paterson Street, Suite, #2200, NJ 08901, USA Department of Neurology, UMDNJ-Robert Wood Johnson Medical School, 125 Paterson Street, Suite #2200, NJ 08901, USA
Adriana Fitzsimmons
Affiliation:
Department of Psychiatry, UMDNJ-Robert Wood Johnson Medical School, 125 Paterson Street, Suite, #2200, NJ 08901, USA
*
*Corresponding author. Tel.: +1-732-235-7647; fax: +1-732-235-7677. E-mail address: [email protected] (K.R. Kaufman).
Get access

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

ModafinilDepressionTreatmentMonotherapyPsychostimulantsAntidepressants
Type
Case report
Information
European Psychiatry , Volume 17 , Issue 3 , May 2002 , pp. 167 - 169
Copyright
Copyright © Éditions scientifiques et médicales Elsevier SAS. 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

1

Presented at the XXIInd CINP Congress, Brussels, Belgium, July 9–13, 2000. Conflicts of interest: no grant funds were used to support the work reported in this paper or its publication.

References

Engber, TMKoury, EJDenniss, SAMiller, MSContreras, PCBhat, RVDifferential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent Modafinil. Neurosci. Lett. 1998;241(2–3): 95–8.CrossRefGoogle ScholarPubMed
Feighner, JPHerbstein, JDamlouji, NCombined MAOI, TCA and direct stimulant therapy of treatment-resistant depression. J. Clin. Psychiatry 1985;46(6):206–9.Google ScholarPubMed
Ferraro, LAntonelli, TTanganelli, SO’Connor, WTPerez de la Mora, MMendez-Franco, JRambert, FAFuxe, KKThe vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade. Neuropsychopharmacology 1999;29(4): 346–56.CrossRefGoogle Scholar
Gold, LHBalster, RLEvaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil. Psychopharmacology (Berlin) 1996;126:286–92.CrossRefGoogle ScholarPubMed
Jacobvitz, DTreatment of attentional and hyperactivity problems in children with sympathomimetic drugs: A comprehensive review. J. Am. Acad. Child Adolesc. Psychiatry 1990;29: 677–88.CrossRefGoogle ScholarPubMed
Jasinski, DRAn evaluation of the abuse potential of modafinil using methylphenidate as a reference. J. Psychopharmacol. 2000;14(1):53–60.CrossRefGoogle ScholarPubMed
Lin, JSHou, YJouvet, MPotential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc. Natl. Acad. Sci. USA 1996;93:14128–33.Google ScholarPubMed
Masand, PSTesar, GEUse of stimulants in the medically ill. Psychiatr. Clin. North Am. 1996;19(3):515–47.CrossRefGoogle ScholarPubMed
Menza, MAKaufman, KRCastellanos, AMModafinil augmentation of antidepressant treatment in depression. J. Clin. Psychiatry 2000;61(5):378–81.CrossRefGoogle ScholarPubMed
Robertson, PDeCory, HHMadan, AParkinson, AIn vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil. Drug Metab. Dispos. 2000;28(6): 664–71.Google ScholarPubMed
Stoll, ALPillay, SSDiamond, LWorkum, SBCole, JOMeth-ylphenidate augmentation of serotonin selective reuptake inhibitors: a case series. J. Clin. Psychiatry 1996;57(2):72–6.Google Scholar
Wong, YNSimcoe, DHartman, LNLaughton, WBKing, SPMcCormick, GCGrebow, PEA double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. J. Clin. Pharmacology 1999;39(1):30–40.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.